Isis Pharmaceuticals, Inc. - Strategy and SWOT Report
is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Isis Pharmaceuticals, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Isis Pharmaceuticals, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Isis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
Intelligence on Isis Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Isis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Isis Pharmaceuticals (Isis or 'the company') uses antisense technology, a drug discovery platform, to discover and develop novel drugs for its product pipeline and also for its partners. The company primarily operates in the US. It is headquartered in Carlsbad, California, and employed 304 people as of February 17, 2014. The company recorded revenues of $147.3 million during the financial year ended December 2013 (FY2013), an increase of 44.3% over FY2012. The operating loss of the company was $51.7 million in FY2013, as compared to an operating loss of $68.9 million in FY2012. The net loss of the company was $60.6 million in FY2013, as compared to a net loss of $65.5 million in FY2012.
Reasons to Purchase:
Gain understanding of Isis Pharmaceuticals, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Isis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Isis Pharmaceuticals, Inc.’s business structure, strategy and prospects